Tocotrienols induce IKBKAP expression: A possible therapy for familial dysautonomia

Biochemical and Biophysical Research Communications

Volumn 306, Issue 1, 2003, Pages 303-309

  Anderson, Sylvia L ^a   Qiu, Jinsong ^a   Rubin, Berish Y ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

Familial dysautonomia; IKAP; IKBKAP; Tocotrienol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DYSAUTONOMIA; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPPLEMENTATION; UPREGULATION;

EID: 0038392607     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00971-9     Document Type: Article

References (28)

1. Riley C.M., Day R.L., Greely D., Langford W.S. Central autonomic dysfunction with defective lacrimation. Pediatrics. 3:1949;468-477.
2. Axelrod F.B., Nachtigal R., Dancis J. Familial Dysautonomia: diagnosis, pathogenesis and management. Adv. Pediatr. 21:1974;75-96.
3. Axelrod F.B. Familial Dysautonomia. Robertson D., Low P.A., Polinsky R.J. Primer on the Autonomic Nervous System. 1996;242-249 Academic Press, San Diego.
4. Anderson S.L., Coli R., Daly I.W., Kichula E.A., Rork M.J., Volpi S.A., Ekstein J., Rubin B.Y. Familial Dysautonomia is caused by mutations of the IKAP gene. Am. J. Hum. Genet. 68:2001;753-758.
5. Slaugenhaupt S.A., Blumenfeld A., Gill S.P., Leyne M., Mull J., Cuajungco M.P., Liebert C.B., Chadwick B., Idelson M., Reznik L., Robbins C.M., Makalowska I., Brownstein M.J., Krappmann D., Scheidereit C., Maayan C., Axelrod F.B., Gusella J.F. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet. 68:2001;598-605.
6. Cohen L., Henzel W.J., Baeuerle P.A. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-297.
7. Krappmann D., Hatada E.N., Tegethoff S., Li J., Klippel A., Giese K., Baeuerle P.A., Scheidereit C. The IκB kinase (IKK) complex is tripartite and contains IKKγ but not IKAP as a regular component. J. Biol. Chem. 275:2000;29779-29787.
8. Otero G., Fellows J., Li Y., de Bizemont T., Dirac A.M., Gustafsson C.M., Erdjument-Bromage H., Tempst P., Svejstrup J.Q. Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol. Cell. 3:1999;109-118.
9. Hawkes N.A., Otero G., Winkler G.S., Marshall N., Dahmus M.E., Krappmann D., Scheidereit C., Thomas C.L., Schiavo G., Erdjument-Bromage H., Tempst P., Svejstrup J.Q. Purification and characterization of the human elongator complex. J. Biol. Chem. 277:2002;3047-3052.
10. Holmberg C., Katz S., Lerdrup M., Herdegen T., Jaattela M., Aronheim A., Kallunki T. A novel specific role for I kappa B kinase complex-associated protein in cytosolic stress signaling. J. Biol. Chem. 277:2002;31918-31928.
11. Huie M.L., Tsujino S., Sklower Brooks S., Engel A., Elias E., Bonthron D.T., Bessley C., Shanske S., DiMauro S., Goto Y.I., Hirschhorn R. Glycogen storage disease type II: identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions/deletions in the acid alpha-glucosidase locus of patients of differing phenotype. Biochem. Biophys. Res. Commun. 244:1998;921-927.
12. Boerkoel C.F., Exelbert R., Nicastri C., Nichols R.C., Miller F.W., Plotz P.H., Raben N. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am. J. Hum. Genet. 56:1995;887-897.
13. Beck S., Penque D., Garcia S., Gomes A., Farinha C., Mata L., Gulbenkian S., Gil-Ferreira K., Duarte A., Pacheco P., Barreto C., Lopes B., Cavaco J., Lavinha J., Amaral M.D. Cystic fibrosis patients with the 3272-26A. → G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane Hum. Mutat. 14:1999;133-144.
14. Kure S., Hou D.C., Suzuki Y., Yamagishi A., Hiratsuka M., Fukuda T., Sugie H., Kondo N., Matsubara Y., Narisawa K. Glycogen storage disease type Ib without neutropenia. J. Pediatr. 137:2000;253-256.
15. Svenson I.K., Ashley-Koch A.E., Pericak-Vance M.A., Marchuk D.A. A second leaky splice-site mutation in the spastin gene. Am. J. Hum. Genet. 69:2001;1407-1409.
16. Svenson I.K., Ashley-Koch A.E., Gaskell P.C., Riney T.J., Cumming W.J., Kingston H.M., Hogan E.L., Boustany R.M., Vance J.M., Nance M.A., Pericak-Vance M.A., Marchuk D.A. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am. J. Hum. Genet. 68:2001;1077-1085.
17. Goidin D., Mamessier A., Staquet M.J., Schmitt D., Berthier-Vergnes O. Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal. Biochem. 295:2001;17-21.
18. Rubin B.Y., Anderson S.L., Xing L., Powell R.J., Tate W.P. Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266:1991;24245-24248.
19. Rubin B.Y., Anderson S.L., Sullivan S.A., Williamson B.D., Carswell E.A., Old L.J. Purification and characterization of a human tumor necrosis factor from the LuKII cell line. Proc. Natl. Acad. Sci. USA. 82:1985;6637-6641.
20. Cuajungco M.P., Leyne M., Mull J., Gill S.P., Lu W., Zagzag D., Axelrod F.B., Maayan C., Gusella J.F., Slaugenhaupt S.A. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with Familial Dysautonomia. Am. J. Hum. Genet. 72:2003;749-758.
21. Biedler J.L., Spengler B.A., Ross R.A. Human neuroblastoma cell differentiation. Raghavan D., Sher H.I., Leibel S.A., Lange P.H. Principles and Practice of Genitourinary Oncology. 1997;1053-1061 Lippincott-Raven, Philadelphia.
22. Lazarova D.L., Spengler B.A., Biedler J.L., Ross R.A. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts. Oncogene. 18:1999;2703-2710.
23. Serbinova E., Kagan V., Han D., Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 10:1991;263-275.
24. Serbinova E.A., Packer L. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Methods Enzymol. 234:1994;354-366.
25. Pearce B.C., Parker R.A., Deason M.E., Qureshi A.A., Wright J.J. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35:1992;3595-3606.
26. Pearce B.C., Parker R.A., Deason M.E., Dischino D.D., Gillespie E., Qureshi A.A., Volk K., Wright J.J. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J. Med. Chem. 37:1994;526-541.
27. Sen C.K., Khanna S., Roy S., Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275:2000;13049-13055.
28. Landes N., Pfluger P., Kluth D., Birringer M., Ruhl R., Bol G.F., Glatt H., Brigelius-Flohe R. Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 65:2003;269-273.